0002116194-26-000001.txt : 20260309
0002116194-26-000001.hdr.sgml : 20260309
20260306191128
ACCESSION NUMBER: 0002116194-26-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering
FILED AS OF DATE: 20260309
DATE AS OF CHANGE: 20260306
EFFECTIVENESS DATE: 20260309
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: AirNexis Therapeutics, Inc.
CENTRAL INDEX KEY: 0002116194
ORGANIZATION NAME:
EIN: 331915170
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-575781
FILM NUMBER: 26732775
BUSINESS ADDRESS:
STREET 1: 1001 PAGE MILL ROAD
STREET 2: BUILDING 4, SUITE 200B
CITY: PALO ALTO
STATE: CA
ZIP: 94304
BUSINESS PHONE: (619) 604-7904
MAIL ADDRESS:
STREET 1: 1001 PAGE MILL ROAD
STREET 2: BUILDING 4, SUITE 200B
CITY: PALO ALTO
STATE: CA
ZIP: 94304
D
1
primary_doc.xml
X0708
D
LIVE
0002116194
AirNexis Therapeutics, Inc.
1001 PAGE MILL ROAD
BUILDING 4, SUITE 200B
PALO ALTO
CA
CALIFORNIA
94304
(619) 604-7904
DELAWARE
None
None
Corporation
true
2024
Maria
Fardis
1001 Page Mill Rd.
Building 4, Suite 200B
Palo Alto
CA
CALIFORNIA
94304
Executive Officer
Director
Anna
Chen
1001 Page Mill Rd.
Building 4, Suite 200B
Palo Alto
CA
CALIFORNIA
94304
Director
Evan
Caplan
1001 Page Mill Rd.
Building 4, Suite 200B
Palo Alto
CA
CALIFORNIA
94304
Director
Colin
Walsh
1001 Page Mill Rd.
Building 4, Suite 200B
Palo Alto
CA
CALIFORNIA
94304
Director
Jill
Carroll
1001 Page Mill Rd.
Building 4, Suite 200B
Palo Alto
CA
CALIFORNIA
94304
Director
James
Li
1001 Page Mill Rd.
Building 4, Suite 200B
Palo Alto
CA
CALIFORNIA
94304
Executive Officer
Director
Biotechnology
Decline to Disclose
- 06b
false
2026-01-09
true
true
false
0
200000000
62000000
138000000
false
13
0
0
0
false
AirNexis Therapeutics, Inc.
/s/ Maria Fardis
Maria Fardis
CEO
2026-03-06